- TECHNOLOGY FEATURE
Coronavirus vaccines get a biotech boost
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 583, 647-649 (2020)
doi: https://doi.org/10.1038/d41586-020-02154-2
References
Pardi, N. et al. Nature Commun. 9, 3361 (2020).
Awasthi, S. et al. Sci. Immunol. 4, eaaw7083 (2019).
Pardi, N. et al. Nature Commun. 8, 14630 (2020).
Jackson, L. A. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2022483 (2020).
Tebas, P. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1708120 (2017).
Kwong, P. D. et al. Immunol. Rev. 275, 108–128 (2017).
Brito, R. C. F. et al. Int. J. Mol. Sci. 18, 371 (2017).
Brito, R. C. F. et al. Vaccines 7, 162 (2019).
McLellan, J. S. et al. Science 340, 1113–1117 (2013).
McLellan, J. S. et al. Science 342, 592–598 (2013).
Crank, M. C. et al. Science 365, 505–509 (2019).
Henderson, R. et al. Preprint at bioRxiv https://doi.org/10.1101/2020.05.18.102087 (2020).
Hsieh, C.-L. et al. Preprint at bioRxiv https://doi.org/10.1101/2020.05.30.125484 (2020).